Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer
Clinical trial NCT05283616 · COMPLETED
Trial details
- NCT number
- NCT05283616
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-15
- Primary completion
- 2019-10-10
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.